arGEN-X SE ADR (ARGX): Price and Financial Metrics

arGEN-X SE ADR (ARGX): $591.82

17.28 (+3.01%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

F

Add ARGX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#84 of 332

in industry

ARGX Price/Volume Stats

Current price $591.82 52-week high $611.22
Prev. close $574.54 52-week low $327.73
Day low $578.61 Volume 382,200
Day high $592.29 Avg. volume 309,598
50-day MA $555.08 Dividend yield N/A
200-day MA $456.71 Market Cap 35.39B

ARGX Stock Price Chart Interactive Chart >


arGEN-X SE ADR (ARGX) Company Bio


argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancers, today announced its 2021 corporate priorities and highlighted recent achievements from its late-stage immunology pipeline driven by its FcRn antagonist, efgartigimod. Additionally, the Company announced interim data from the Phase 2 CULMINATE trial of cusatuzumab in development with Cilag GmbH International, an affiliate of Janssen, and provided financial guidance for 2021. (Source:Wiki)


ARGX Latest News Stream


Event/Time News Detail
Loading, please wait...

ARGX Latest Social Stream


Loading social stream, please wait...

View Full ARGX Social Stream

ARGX Price Returns

1-mo 4.10%
3-mo 14.54%
6-mo 61.23%
1-year 20.29%
3-year 117.33%
5-year 317.48%
YTD 55.57%
2023 0.42%
2022 8.18%
2021 19.08%
2020 83.21%
2019 67.09%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!